A research team led by scientists from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) has determined how several antibodies induced by Epstein-Barr virus (EBV), a herpesvirus that causes infectious mononucleosis and is associated with certain cancers, block infection of cells grown in the laboratory.
With Antibody-Drug Combination, NIAID Scientists Improve Outcomes of Bone Marrow Transplants in Mice
In a new paper published February 6 in Nature Communications, researchers from NIAID and Harvard University describe a way to better prepare a recipient to tolerate bone marrow donation, using an antibody-drug conjugate that combines a cell-targeting antibody with a cell toxin, which the antibody carries as cargo.
GE Healthcare has partnered with the Nigeria Sovereign Investment Authority (NSIA) to supply latest technology in computed tomography (CT), Discovery RT, to Lagos University Teaching Hospital for its modern NSIA- LUTH Cancer Center, commissioned by President Muhammadu Buhari.
GW Cancer Center Approved for $300,000 Engagement Award for Project on Cancer Survivorship Care Quality
A team from the George Washington University (GW) Cancer Center has been approved for a $300,000 funding award through the Eugene Washington PCORI Engagement Awards (Engagement Awards) program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).
NTP releases final reports on rat and mouse studies of radio frequency radiation like that used in 2G and 3G cell phone technologies. The National Toxicology Program (NTP) concluded there is clear […]
WHO has announced a new Global Initiative for Childhood Cancer – with the aim of reaching at least a 60% survival rate for children with cancer by 2030, thereby saving an additional one million lives.
More than 3 million people died as a result of harmful use of alcohol in 2016, according a report released by the World Health Organization (WHO).